Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	44.45	197.73	136.88
Graham Fair Price	40.65	3.86	2.75
PEG	-65.38	-0.06	0.18
Price/Book	-21.09	0.28	0.36
Price/Cash Flow	102.90	7.71	-3.80
Prices/Earnings	61.00	-6.08	-15.59
Price/Sales	-54.14	1.22	2.65
Price/FCF	102.90	7.71	-3.80
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-47.98	0.08	0.16
Operating Margin	-30.17	-0.05	0.07
ROA	-106.24	< 0.005	< 0.005
ROE	< 0.005	-0.01	-102.33
ROIC	< 0.005	< 0.005	-36.93
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.03	-93.09
Dividends QOQ	-0.04	0.13	247.21
EBIT QOQ	1.24	-2.19	76.03
EPS QOQ	0.89	-1.00	12.65
FCF QOQ	-13.74	1.38	-89.92
Revenue QOQ	-0.66	0.70	7.03
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2272.98	1149.10	-49.45
Days Sales Outstanding (DSO)	371.62	308.20	-17.06
Inventory Turnover	0.04	0.08	97.81
Debt/Capitalization	0.69	0.70	0.86
Quick Ratio	0.46	0.60	31.33
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	7.65	10.50	37.28
Cash	4.55	2.22	-51.21
Capex	-0.06	0.03	-47.65
Free Cash Flow	-0.72	0.28	-61.55
Revenue	1.03	1.75	70.12
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.74	1.64	-5.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	113.09	169.79	50.14
Naive Interpretation	Member

06 - Financial Health · Weak

Rating